PRESS RELEASE published on 05/12/2023 at 02:25, 2 years 6 months ago bettermoo(d) Unveils First Insights of its Highly Anticipated MoodrinkTM Innovation: Rivals and, in Many Cases, Exceeds the Nutritional Aspects of Traditionally Consumed Cow's Milk
PRESS RELEASE published on 05/10/2023 at 01:55, 2 years 6 months ago bettermoo(d) Partners with Leading National Sales Powerhouse Ahead of Initial Moodrink(TM) Launch in September
PRESS RELEASE published on 05/06/2023 at 02:00, 2 years 6 months ago bettermoo(d) to Raise $10,000,000 at $6.80 per Unit – Eying September Moodrink launch – and Promotes Former Coca-Cola Subsidiary CEO to Chairman, and bettermoo(d) Founder Nima Bahrami as Company’s New CEO
PRESS RELEASE published on 04/13/2023 at 00:10, 2 years 7 months ago bettermoo(d) Schedules Highly Anticipated Commercial Production for Its Dairy-Alternative "Moodrink"
PRESS RELEASE published on 01/14/2023 at 20:00, 2 years 10 months ago bettermoo(d) Announces Non-Brokered Private Placement of up to $3 Million
Published on 12/05/2025 at 02:35, 4 hours 32 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 7 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 2 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 7 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 37 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 16 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 42 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 52 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 56 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 13 hours 7 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 22 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 23 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
